Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Breath Company
Los Angeles, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The Breath Company (marketed as TheraBreath in the United States) is a leading oral care company focused on the treatment of halitosis, dry mouth, and gum health. Clinical studies have shown that its proprietary stabilized chlorine dioxide (OXYD-8) formulations eliminate over 98% of volatile sulfur compounds (VSCs) that cause bad breath and provide protection for up to 12-24 hours.
- Therapeutic areas
- Infectious DiseasesOtherGastroenterology
- Modalities
- Small moleculeTopical formulation
- Industry
- Biotech
02
Partnerships
BootsAmazonWalmart
Beyond the preview
Go deeper on The Breath Company.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The Breath Company.